Second therapeutic candidate
TDP43 proteinopathy
Phase 1Active
Key Facts
About SOCIUM
Socium uses AI-driven phosphorylation analysis to discover and develop novel therapeutics for neurodegenerative diseases with high unmet need.
View full company profile